Clinical Trial Update: Personalized Immunotherapy in Sepsis [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating a personalized immunotherapy approach for sepsis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sepsis

Snippet

Sponsor: Hellenic Institute for the Study of Sepsis | Conditions: Sepsis | Phase 2 | Status: COMPLETED